1. Home
  2. LOOP vs RFL Comparison

LOOP vs RFL Comparison

Compare LOOP & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

HOLD

Current Price

$1.50

Market Cap

65.7M

Sector

Industrials

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.23

Market Cap

63.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOOP
RFL
Founded
2010
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Real Estate
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
65.7M
63.5M
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
LOOP
RFL
Price
$1.50
$1.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
112.3K
68.9K
Earning Date
01-14-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
27.27
28.28
EPS
N/A
N/A
Revenue
$10,889,000.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$174.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7016.99
43.96
52 Week Low
$0.88
$1.12
52 Week High
$2.29
$3.19

Technical Indicators

Market Signals
Indicator
LOOP
RFL
Relative Strength Index (RSI) 65.87 41.84
Support Level $1.44 $1.15
Resistance Level $1.75 $1.59
Average True Range (ATR) 0.11 0.09
MACD 0.01 -0.01
Stochastic Oscillator 83.87 7.41

Price Performance

Historical Comparison
LOOP
RFL

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: